CCCC Financials
C4 Therapeutics Inc - Financial statements & key metrics
Stock Price
$2.92
Market Cap
$282.98M
EPS
$-1.27
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$35.58M
Gross Profit
-
Operating Income
-
Net Income
$-105.32M
EPS (Diluted)
$-1.52
Balance Sheet Highlights
Total Assets
$349.60M
Total Liabilities
$133.62M
Shareholders Equity
-
Cash & Equivalents
$55.50M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-65.16M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Gross Margin
75.0%
Operating Margin
-2.1%
Net Margin
-2.9%
ROE
-0.4%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is CCCC revenue?
CCCC's most recent quarterly revenue was $35.58M. Annual revenue can be calculated by summing the four most recent quarters.
Is CCCC profitable?
CCCC reported a loss of $105.32M in the most recent quarter. The net profit margin is -2.9%.
What is CCCC market cap?
CCCC has a market capitalization of $282.98M, making it a small-cap stock.
Does CCCC have debt?
View CCCC's balance sheet for debt information.
What is CCCC cash flow?
Cash flow data is available in the full financial statements.